Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis.

Chinnadurai, Raghavan; Viswanathan, Sowmya; Moll, Guido

Chinnadurai, Raghavan; Viswanathan, Sowmya; Moll, Guido.

Afiliação

Chinnadurai R; Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA, United States.
Viswanathan S; Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada.
Moll G; Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Front Immunol ; 14: 1192636, 2023.

Article em En | MEDLINE | ID: mdl-37153609

Assuntos

Imunomodulação; Células-Tronco Mesenquimais

Palavras-chave

and regeneration; cell product manufacturing; cell therapy; immunomodulation; mechanism of action (MOA); mesenchymal stromal/stem cells (MSC); potency analysis; safety and efficacy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunomodulação / Células-Tronco Mesenquimais Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google